Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACE | P12821 | 6/20 | 0.54 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.54 |
| ▸ | AGTR2 | P50052 | 1/20 | 0.54 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.54 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.53 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Temocapril SCHEMBL10377817 | 1.00 | ACE (0.54) | ACEABCB11AGTR2PDE3ATDP1 | |
| Temocapril SCHEMBL6506860 | 1.00 | ACE (0.54) | ACEABCB11AGTR2PDE3ATDP1 | |
| Temocapril SCHEMBL10376961 | 1.00 | ACE (0.54) | ACEABCB11AGTR2PDE3ATDP1 | |
| Temocapril SCHEMBL1650365 | 1.00 | ACE (0.54) | ACEABCB11AGTR2PDE3ATDP1 | |
| Temocapril SCHEMBL6444389 | 1.00 | ACE (0.54) | ACEABCB11AGTR2PDE3ATDP1 | |
| Temocapril SCHEMBL10377818 | 1.00 | ACE (0.54) | ACEABCB11AGTR2PDE3ATDP1 | |
| Temocapril SCHEMBL10377820 | 1.00 | ACE (0.54) | ACEABCB11AGTR2PDE3ATDP1 | |
| Temocapril SCHEMBL121391 | 0.99 | KDM4E (0.55) | ACEABCB11AGTR2PDE3ATDP1 | |
| Temocapril SCHEMBL10431733 | 0.99 | KDM4E (0.55) | ACEABCB11AGTR2PDE3ATDP1 | |
| Temocapril SCHEMBL10431734 | 0.99 | KDM4E (0.55) | ACEABCB11AGTR2PDE3ATDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 7022 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026087680-A1 | TREATMENT FOR CARDIOVASCULAR DISEASE | SAPREME TECHNOLOGIES B.V. (NL) | 2026-04-30 | — | — | WO | claimed |
| EP-4595974-A2 | THERAPEUTIC COMBINATIONS OF TDFRPS AND ADDITIONAL AGENTS AND METHODS OF USE | Carlson, William D. (US) | 2025-08-06 | — | — | EP | claimed |
| WO-2025111482-A1 | COMPLEXING AGENT SALT FORMULATIONS OF PHARMACEUTICAL COMPOUNDS AT LOW STOICHIOMETRIC RATIOS | BEXSON BIOMEDICAL, INC. (US) | 2025-05-30 | — | — | WO | claimed |
| US-20250082608-A1 | TREATMENT AND PREVENTION OF GLOMERULAR DISEASE | SINGAPORE HEALTH SERVICES PTE LTD. (SG) | 2025-03-13 | — | — | US | claimed |
| US-12194032-B2 | Method of treating focal segmental glomerulosclerosis | CHEMOCENTRYX, INC. (US) | 2025-01-14 | — | — | US | claimed |
| US-20240374587-A1 | MEDICINE FOR PREVENTION AND TREATMENT OF DISEASES LINKED TO ANTI-OBESITY ACTIVITY | SHIONOGI & CO., LTD. (JP) | 2024-11-14 | — | — | US | claimed |
| EP-4134080-B1 | CCR2 INHIBITORS FOR USE IN TREATING RENAL DISEASES | CHEMOCENTRYX INC (US) | 2024-11-13 | — | — | EP | claimed |
| EP-4448096-A1 | TREATMENT AND PREVENTION OF GLOMERULAR DISEASE | Singapore Health Services Pte. Ltd. (SG) | 2024-10-23 | — | — | EP | claimed |
| WO-2024210922-A1 | COMPOSITIONS FOR ANTIHYPERTENSIVE DRUGS | INNOVATOR THERAPEUTICS, LLC. (US) | 2024-10-10 | — | — | WO | claimed |
| EP-3083573-B1 | INHIBITORS OF THE RENAL OUTER MEDULLARY POTASSIUM CHANNEL | MERCK SHARP & DOHME LLC (US) | 2024-08-07 | — | — | EP | claimed |
| EP-0808171-A2 | COMBINATION OF ANGIOTENSIN CONVERTING ENZYME INHIBITOR, SIDE-EFFECT-REDUCED AMOUNT OF ALDOSTERONE ANTAGONIST AND DIURETIC | G.D. SEARLE & CO. (US) | 1997-11-26 | — | — | EP | claimed |
| EP-0808172-A2 | COMBINATION OF ANGIOTENSIN CONVERTING ENZYME INHIBITOR AND SIDE-EFFECT-REDUCED AMOUNT OF ALDOSTERONE ANTAGONIST | G.D. SEARLE & COMPANY (US) | 1997-11-26 | — | — | EP | claimed |
| WO-1997002032-A1 | METHOD OF TREATING RENAL DISEASE USING AN ACE INHIBITOR AND AN AII ANTAGONIST | MERCK & CO., INC. (US) | 1997-01-23 | — | — | WO | claimed |
| WO-1996024372-A2 | COMBINATION OF ANGIOTENSIN CONVERTING ENZYME INHIBITOR, SIDE-EFFECT-REDUCED AMOUNT OF ALDOSTERONE ANTAGONIST AND DIURETIC | G.D. SEARLE & CO. (US) | 1996-08-15 | — | — | WO | claimed |
| WO-1996024373-A2 | COMBINATION OF ANGIOTENSIN CONVERTING ENZYME INHIBITOR AND SIDE-EFFECT-REDUCED AMOUNT OF ALDOSTERONE ANTAGONIST | G.D. SEARLE & CO. (US) | 1996-08-15 | — | — | WO | claimed |
| EP-0643580-A4 | COMBINATIONS OF ACE INHIBITORS AND DIURETICS. | — | 1995-04-19 | — | — | EP | claimed |
| EP-0643580-A1 | COMBINATIONS OF ACE INHIBITORS AND DIURETICS | MERCK & CO. INC. (US) | 1995-03-22 | — | — | EP | claimed |
| WO-1994028924-A1 | COMBINATION OF ANGIOTENSIN CONVERTING ENZYME INHIBITORS AND AII ANTAGONISTS | LABORATOIRES MERCK SHARP ET DOHME CHIBRET (FR) | 1994-12-22 | — | — | WO | claimed |
| EP-0629408-A1 | Combination of angiotensin converting enzyme inhibitors and AII antagonists | LABORATOIRES MERCK, SHARP & DOHME-CHIBRET (FR) | 1994-12-21 | — | — | EP | claimed |
| WO-1993017685-A1 | COMBINATIONS OF ACE INHIBITORS AND DIURETICS | MERCK & CO., INC. (US) | 1993-09-16 | — | — | WO | claimed |